Stability-indicating HPTLC determination of curcumin in bulk drug and pharmaceutical formulations
- 1 September 2005
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 39 (1-2) , 132-138
- https://doi.org/10.1016/j.jpba.2005.03.021
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Oxygen radical scavenging activity of curcuminPublished by Elsevier ,2002
- Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cellsCancer Letters, 2001
- Inhibition of interleukin-12 production in lipopolysaccharide-activated macrophages by curcuminEuropean Journal of Pharmacology, 1999
- Curcumin inhibits Th1 cytokine profile in CD4+ T cells by suppressing interleukin‐12 production in macrophagesBritish Journal of Pharmacology, 1999
- The anti-oxidant activity of turmeric (Curcuma longa)Journal of Ethnopharmacology, 1995
- Anti-tumour and antioxidant activity of natural curcuminoidsCancer Letters, 1995
- Analysis of Curcuminoids by High-Performance Liquid ChromatographyPublished by American Chemical Society (ACS) ,1994
- Inhibition of neutrophil response by curcuminInflammation Research, 1989
- Extracts from two frequently consumed spices — Cumin (Cuminum cyminum) and turmeric (Curcuma longa) — Inhibit platelet aggregation and alter eicosanoid biosynthesis in human blood plateletsProstaglandins, Leukotrienes & Essential Fatty Acids, 1989
- Anti-inflammatory and irritant activities of curcumin analogues in ratsInflammation Research, 1982